Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The role of laquinimod in modulation of the immune response in relapsing-remitting multiple sclerosis: Lessons from gene expression signatures.
COMPARE: pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects.
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort.
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis.
[Cognitive impairment in demyelinating disease].
Association of IL4 and IL4R polymorphisms with multiple sclerosis susceptibility in Caucasian population: A meta-analysis.
Multiple sclerosis causing a partial sixth nerve palsy.
Twin studies and the heritability of MS: a conclusion.
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.
Assessment of cerebral venous return by a novel plethysmography method.
The Submaximal Clinical Exercise Tolerance Test (SXTT) to Establish Safe Exercise Prescription Parameters for Patients with Chronic Disease and Disability.
Contribution of imaging to the diagnosis of optic neuropathies.
Characterization of human platelet binding of recombinant T cell receptor ligand.
Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis.
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
miRNA in multiple sclerosis: search for novel biomarkers.
Psoriasis during natalizumab treatment for multiple sclerosis.
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Zebrafish screen identifies novel compound with selective toxicity against leukemia.
Multiple sclerosis and oligodendroglioma: an exceptional association.
Disease-modifying drugs for multiple sclerosis and JC virus expression.
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.

Pages